Drug Shortage Report for AURO-ALENDRONATE

Last updated on 2020-05-23 History
Report ID 112862
Drug Identification Number 02388553
Brand name AURO-ALENDRONATE
Common or Proper name Alendronic Acid
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 70MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 1x4
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-22
Estimated end date
Actual end date 2020-05-22
Shortage status Resolved
Updated date 2020-05-23
Company comments
Health Canada comments
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-05-23 English Compare
v4 2020-05-20 French Compare
v3 2020-05-20 English Compare
v2 2020-04-23 French Compare
v1 2020-04-23 English Compare